OncoMed Pharmaceuticals Inc
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|---|
| Revenue | $7.8M | $6.2M | $25.2M | $25.9M | $39.6M | $37.8M |
| Operating income | −$10.0M | −$41.0M | −$103.4M | −$85.6M | −$50.6M | −$23.9M |
| Net income | −$5.6M | −$22.6M | −$103.1M | −$85.4M | −$50.0M | −$26.1M |
| Total assets | $65.1M | $110.3M | $195.5M | $237.9M | $247.8M | $333.7M |
| Total liabilities | $16.8M | $158.9M | $218.5M | $234.3M | $171.5M | $215.6M |
| Equity | $48.2M | −$48.6M | −$23.0M | $3.6M | $76.4M | $118.1M |
| EPS (diluted) | $-0.21 | — | — | — | — | — |
| Shares out. | 38.3M | 37.4M | 30.3M | 29.9M | 29.5M | 29.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- −128.0%
- Net margin
- −71.0%
- Return on equity
- −11.6%
- Return on assets
- −8.6%
- Return on capital (ROCE)
- −19.2%
- Liabilities / assets
- 25.9%
- Debt / equity
- 0.35×
- Book value / share
- $1.26
- Revenue growth (YoY)
- 26.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- -11.01distress
- Accruals / assets
- 60.4%high accruals
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsApr 23, 2019
- Shareholder vote · Other material eventApr 17, 2019
- Entered a material agreement · Other material eventMar 15, 2019
- Results of operationsMar 7, 2019
- Delisting / listing-standard noticeJan 28, 2019
- Entered a material agreement · Costs from exit or disposal · Director / officer change · Regulation FD disclosure · Other material eventDec 6, 2018
- Results of operationsNov 1, 2018
- Other material eventOct 17, 2018
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BFORM 15-12BMay 3, 2019
- SC 13D/AAMENDMENT NO. 1 TO THE SCHEDULE 13DApr 26, 2019
- S-8 POSFORM S-8 POSApr 24, 2019
- S-8 POSFORM S-8 POSApr 24, 2019
- S-8 POSFORM S-8 POSApr 24, 2019
- S-8 POSFORM S-8 POSApr 24, 2019
- S-8 POSFORM S-8 POSApr 24, 2019
- S-8 POSFORM S-8 POSApr 24, 2019
- 8-KFORM 8-KApr 23, 2019
- 4FORM 4 SUBMISSIONApr 23, 2019
- 4FORM 4 SUBMISSIONApr 23, 2019
- 4FORM 4 SUBMISSIONApr 23, 2019
- 4FORM 4 SUBMISSIONApr 23, 2019
- 4FORM 4 SUBMISSIONApr 23, 2019
- 4FORM 4 SUBMISSIONApr 23, 2019
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.